Sunovion Pharma and San Diego-based drug discovery platform company Afraxis have entered into a partnership agreement to use the unique enhanced spine platform (ESP), to boost Sunovion’s preclinical central nervous system (CNS) drug ...
Tags: Sunovion Pharma, Afraxis